| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910999 | Lung Cancer | 2014 | 4 Pages |
Abstract
Re-biopsy of advanced NSCLC is feasible in the real-world setting, with acceptable adverse events. Guidelines are needed on the indications of re-biopsy, the choice of procedure, the sampling site, and laboratory analysis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christos Chouaid, Cecile Dujon, Pascal Do, Isabelle Monnet, Anne Madroszyk, Herve Le Caer, Jean Bernard Auliac, Henri Berard, Pascal Thomas, Herve Lena, Gilles Robinet, Nathalie Baize, Acya Bizieux-Thaminy, Gislaine Fraboulet, Chrystele Locher,